Product
COVIGEN C19
1 clinical trial
1 indication
Indication
COVID-19Clinical trial
A Phase I, Double-blind, Dose-ranging, Randomised, Placebo-controlled Trial to Study the Safety and Immunogenicity of a DNA-based Vaccine Against COVID-19 (COVIGEN) in Healthy Participants Aged 18 to 75 Years OldStatus: Completed, Estimated PCD: 2022-07-30